NR4A1 and breast carcinoma: Tamoxifen is a selective estrogen receptor modulator that can be used to increase the treatment effect in hormone receptor (HR) positive breast cancer diagnosed prior to menopause and metastatic or recurrent HR positive breast cancer [1].